CAMBRIDGE, Mass., March 27, 2018 - rHEALTH LLC announces the issuance of a new patent in the United States for instrument industrial design filed by DNA Medicine Institute, DMI. The design contributes to the diverse measurement capabilities of the rHEALTH digital health platform, which represents broad innovations in testing technologies. The U.S. Patent and Trademark Office...Read more
Recent Posts by DMI
CAMBRIDGE, Mass., Feb. 6, 2018 -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, a digital health solutions company, today announced that the rHEALTH technology is the subject of a partnership with the National Aeronautics and Space Administration (NASA) and the United States Air Force (USAF). This is done via Phase IIE and III...Read more
CAMBRIDGE, Mass., December 5, 2017 - rHEALTH LLC announces the issuance of a new patent in the United States for innovations in optical systems engineering filed by DNA Medicine Institute, DMI. This innovation underscores the portability as well as unique measurement capabilities of the rHEALTH digital diagnostic platform, which represents the miniaturization and automation of...Read more
Dr. Eugene Chan presents at 2017 AACC Conference (San Diego, CA) Dr. Eugene Chan is scheduled to present the rHEALTH technology at the 69th Annual Scientific Meeting of the American Association for Clinical Chemistry (AACC) in San Diego on Monday July 31, 2017 at the Tricorder Session. He will also be at the follow-up Meet...Read more
rHEALTH LLC announces the issuance of three new patents in the United States for innovations in biochemistry and small volume sample collection filed by DNA Medicine Institute, DMI. These innovations increase the analytic capabilities as well as sophistication of the rHEALTH diagnostic platform, which represents the miniaturization and automation of traditional laboratory testing technologies. Most recently,...Read more
Recent Comments by DMI
No comments by DMI yet.